Technology of mammalian cell encapsulation.

Entrapment of mammalian cells in physical membranes has been practiced since the early 1950s when it was originally introduced as a basic research tool. The method has since been developed based on the promise of its therapeutic usefulness in tissue transplantation. Encapsulation physically isolates a cell mass from an outside environment and aims to maintain normal cellular physiology within a desired permeability barrier. Numerous encapsulation techniques have been developed over the years. These techniques are generally classified as microencapsulation (involving small spherical vehicles and conformally coated tissues) and macroencapsulation (involving larger flat-sheet and hollow-fiber membranes). This review is intended to summarize techniques of cell encapsulation as well as methods for evaluating the performance of encapsulated cells. The techniques reviewed include microencapsulation with polyelectrolyte complexation emphasizing alginate-polylysine capsules, thermoreversible gelation with agarose as a prototype system, interfacial precipitation and interfacial polymerization, as well as the technology of flat sheet and hollow fiber-based macroencapsulation. Four aspects of encapsulated cells that are critical for the success of the technology, namely the capsule permeability, mechanical properties, immune protection and biocompatibility, have been singled out and methods to evaluate these properties were summarized. Finally, speculations regarding future directions of cell encapsulation research and device development are included from the authors' perspective.

[1]  G. Reach,et al.  Complement activation by alginate-polylysine microcapsules used for islet transplantation. , 1994, Artificial organs.

[2]  J. Vacanti,et al.  Immunoisolation of xenogeneic islets using a living tissue engineered cartilage barrier. , 1997, Transplantation proceedings.

[3]  W. Hymer,et al.  Pituitary hollow fiber units in vivo and in vitro. , 1981, Neuroendocrinology.

[4]  D. Ecker,et al.  Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. , 1995, Transplantation.

[5]  P. Marchetti,et al.  Preparation and characterization of permselective, biocompatible membranes for the macroencapsulation of pancreatic islets , 1994 .

[6]  Shelley R. Winn,et al.  Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms , 1995, Experimental Neurology.

[7]  K. Shakesheff,et al.  Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. , 1998, Journal of biomaterials science. Polymer edition.

[8]  G. Parmiani,et al.  In vitro "spontaneous" neoplastic transformation of mouse fibroblasts in diffusion chambers. , 1971, Journal of the National Cancer Institute.

[9]  A. Anilkumar,et al.  An encapsulation system for the immunoisolation of pancreatic islets , 1997, Nature Biotechnology.

[10]  Mattheus F. A. Goosen,et al.  Fundamentals of Animal Cell Encapsulation and Immobilization , 1992 .

[11]  H. Sitter,et al.  Amitogenic Alginates: Key to First Clinical Application of Microencapsulation Technology , 1998, World Journal of Surgery.

[12]  K Burczak,et al.  Long-term in vivo performance and biocompatibility of poly(vinyl alcohol) hydrogel macrocapsules for hybrid-type artificial pancreas. , 1996, Biomaterials.

[13]  R. Bretzel,et al.  PROTECTION OF ISLETS OF LANGERHANS FROM INTERLEUKIN‐1 TOXICITY BY ARTIFICIAL MEMBRANES , 1990, Transplantation.

[14]  Myriam Schluep,et al.  Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.

[15]  T. Rytömaa,et al.  REGULATION OF MATURATION RATE OF MOUSE GRANULOCYTES , 1977, Cell and tissue kinetics.

[16]  P. Aebischer,et al.  Treatment of amyotrophic lateral sclerosis using a gene therapy approach. , 1995, European neurology.

[17]  P. Sanberg,et al.  A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy , 1992, Neuroscience & Biobehavioral Reviews.

[18]  M. Goosen,et al.  Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. , 1984, Biochimica et biophysica acta.

[19]  R. L. Broughton,et al.  Microencapsulation of mammalian cells in a water‐insoluble polyacrylate by coextrustion and interfacial precipitation , 1987, Biotechnology and bioengineering.

[20]  M. Suthanthiran,et al.  Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. , 1995, Transplantation.

[21]  P. de Vos,et al.  Factors influencing the adequacy of microencapsulation of rat pancreatic islets. , 1996, Transplantation.

[22]  P. de Vos,et al.  Obstacles in the Application of Microencapsulation in Islet Transplantation , 1993, The International journal of artificial organs.

[23]  R. Robitaille,et al.  Alginate-poly-L-lysine microcapsule biocompatibility: a novel RT-PCR method for cytokine gene expression analysis in pericapsular infiltrates. , 1999, Journal of biomedical materials research.

[24]  M. Pinget,et al.  Influence of corona surface treatment on the properties of an artificial membrane used for Langerhans islets encapsulation: permeability and biocompatibility studies. , 1995, Biomaterials.

[25]  W. J. Tze,et al.  Implantable artificial endocrine pancreas unit used to restore normoglycaemia in the diabetic rat , 1976, Nature.

[26]  C. Stiller,et al.  HISTOLOGICAL AND IMMUNOPATHOLOGICAL ANALYSIS OF RECOVERED ENCAPSULATED ALLOGENEIC ISLETS FROM TRANSPLANTED DIABETIC BB/W RATS , 1992, Transplantation.

[27]  H. Iwata,et al.  Evaluation of Microencapsulated Islets in Agarose Gel as Bioartificial Pancreas by Studies of Hormone Secretion in Culture and by Xenotransplantation , 1989, Diabetes.

[28]  R. L. Broughton,et al.  Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. , 1990, Journal of biomedical materials research.

[29]  W. Stevenson,et al.  Microcapsules through polymer complexation. Part 3: Encapsulation and culture of human Burkitt lymphoma cells in vitro. , 1995, Biomaterials.

[30]  T. Chang,et al.  A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. , 1991, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[31]  S. Bonner-Weir,et al.  Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.

[32]  J. Kordower,et al.  Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons , 1994, The Journal of comparative neurology.

[33]  F. Stohlman,et al.  Growth of Mouse Yolk Sac Cells Cultured in Vivo , 1976, British journal of haematology.

[34]  Wolf Cf,et al.  Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. , 1975 .

[35]  R. Lanza,et al.  Transplantation of encapsulated cells and tissues. , 1997, Surgery.

[36]  J. Remon,et al.  The molecular weight cut‐off of microcapsules is determined by the reaction between alginate and polylysine , 1993, Biotechnology and bioengineering.

[37]  Y. Ikada,et al.  Permeability of filters used for immunoisolation. , 1996, Tissue engineering.

[38]  Y Ikada,et al.  Does immunoisolation need to prevent the passage of antibodies and complements? , 1995, Transplantation proceedings.

[39]  Soon-Shiong Treatment of type I diabetes using encapsulated islets. , 1999, Advanced drug delivery reviews.

[40]  J. Hunt,et al.  Techniques to investigate cellular and molecular interactions in the host response to implanted biomaterials. , 1997, Biomaterials.

[41]  R. Lanza,et al.  Encapsulated cell technology , 1996, Nature Biotechnology.

[42]  S K Young,et al.  Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. , 1996, Transplantation.

[43]  Jeffrey A. Hubbell,et al.  Biomaterials in Tissue Engineering , 1995, Bio/Technology.

[44]  G. Wolters,et al.  Effect of Alginate-Polylysine-Alginate Microencapsulation on In Vitro Insulin Release From Rat Pancreatic Islets , 1991, Diabetes.

[45]  M. Sefton,et al.  Tumor necrosis factor (TNFalpha) production by rat peritoneal macrophages is not polyacrylate surface-chemistry dependent. , 1999, Journal of biomedical materials research.

[46]  M J Lysaght,et al.  Recent progress in immunoisolated cell therapy , 1994, Journal of cellular biochemistry.

[47]  M. Sefton,et al.  Microencapsulation of mammalian cells in a hydroxyethyl methacrylate-methyl methacrylate copolymer: preliminary development. , 1988, Biomaterials, artificial cells, and artificial organs.

[48]  Smadar Cohen,et al.  Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation , 1990 .

[49]  D. Hunkeler,et al.  A SCREENING OF POLYMERS AS BIOMATERIALS FOR CELL ENCAPSULATION , 1997 .

[50]  T A Dyakonov,et al.  Synthetic Strategies for the Preparation of Precursor Polymers and of Microcapsules Suitable for Cellular Entrapment by Polyelectrolyte Complexation of Those Polymersa , 1997, Annals of the New York Academy of Sciences.

[51]  D. Ducassou,et al.  Microencapsulation of isolated pituitary cells by polyacrylamide microlatex coagulation on agarose beads. , 1991, Biomaterials.

[52]  M. Aprahamian,et al.  Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: an in vitro test. , 1992, Biomaterials.

[53]  P. Morris Immunoprotection of therapeutic cell transplants by encapsulation. , 1996, Trends in biotechnology.

[54]  P Aebischer,et al.  TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSION: A PRELIMINARY REPORT , 1994, Transplantation.

[55]  R. C. Johnson,et al.  Neovascularization of synthetic membranes directed by membrane microarchitecture. , 1995, Journal of biomedical materials research.

[56]  Peter C. Johnson,et al.  Meeting Report: Tissue Engineered Medical Products Standards: The Time Is Ripe , 1998 .

[57]  P. Chang,et al.  Permeability of alginate microcapsules to secretory recombinant gene products , 1996, Biotechnology and bioengineering.

[58]  D. Cameron,et al.  Sertoli Cell-Enriched Fractions in Successful Islet Cell Transplantation , 1993, Cell transplantation.

[59]  P. Aebischer,et al.  Mast cells and tissue reaction to intraperitoneally implanted polymer capsules. , 1991, Journal of biomedical materials research.

[60]  Y. Ikada,et al.  A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: rat to mouse xenotransplantation. , 1996, Cell transplantation.

[61]  H. Amemiya,et al.  Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. , 1994, Journal of biomedical materials research.

[62]  F. F. Wang,et al.  Surface modifications of alginate/poly(L-lysine) microcapsular membranes with poly(ethylene glycol) and poly(vinyl alcohol). , 1995, Biomaterials.

[63]  P. Sanberg,et al.  Polymer-Encapsulated PC12 Cells Promote Recovery of Motor Function in Aged Rats , 1993, Experimental Neurology.

[64]  W. Stevenson,et al.  Microcapsules through polymer complexation. II. By complex coacervation of polymers containing a low charge density. , 1991, Biomaterials.

[65]  R. Gates,et al.  REVERSAL OF STREPTOZOTOCIN-INDUCED DIABETES IN RATS BY INTRAPERITONEAL IMPLANTATION OF ENCAPSULATED NEONATAL RABBIT PANCREATIC TISSUE , 1977, The Lancet.

[66]  P. Tresco,et al.  An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats , 1989, Experimental Neurology.

[67]  J. Fink,et al.  Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[68]  R. Taub,et al.  Amelioration of streptozotocin-induced diabetes in mice by the implantation of pancreatic islets in diffusion chambers. , 1976, The Mount Sinai journal of medicine, New York.

[69]  M. Goosen,et al.  Alginate‐Polylysine Microcapsules of Controlled Membrane Molecular Weight Cutoff for Mammalian Cell Culture Engineering , 1987 .

[70]  G. Skjåk‐Braek,et al.  SUCCESSFUL REVERSAL OF SPONTANEOUS DIABETES IN DOGS BY INTRAPERITONEAL MICROENCAPSULATED ISLETS , 1992, Transplantation.

[71]  H. Amemiya,et al.  Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice. , 1992, Transplantation proceedings.

[72]  S. Bystrický,et al.  Interaction of alginates and pectins with cationic polypeptides , 1990 .

[73]  R. Lanza,et al.  Xenotransplantation of cells using biodegradable microcapsules. , 1999, Transplantation.

[74]  C. Calleman,et al.  The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk estimation. , 1996, Drug metabolism reviews.

[75]  P. Bruheim,et al.  Alginate polycation microcapsules. I. Interaction between alginate and polycation. , 1996, Biomaterials.

[76]  Y. Tsutsumi,et al.  Evaluation of Angiogenic Inhibitors with an in vivo Quantitative Angiogenesis Method Using Agarose Microencapsulation and Mouse Hemoglobin Enzyme‐linked Immunosorbent Assay , 1996, Japanese journal of cancer research : Gann.

[77]  P. Marchetti,et al.  Polyurethane-polydimethylsiloxane (PU-PDMS) tubular membranes for pancreatic islet transplantation. Permselectivity and diffusion studies , 1992 .

[78]  R. Padera,et al.  Time course of membrane microarchitecture-driven neovascularization. , 1996, Biomaterials.

[79]  L. Kurz Propagation and hormone production by human normal and malignant trophoblast in rats. II. Choriocarcinoma in Millipore diffusion chambers in rats. , 1971, American journal of obstetrics and gynecology.

[80]  F. Leblond,et al.  Quantitative method for the evaluation of biomicrocapsule resistance to mechanical stress. , 1996, Biomaterials.

[81]  J. A. Hubbell,et al.  Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. , 1994, Biotechnology and bioengineering.

[82]  M. Sefton,et al.  Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel. , 1992, Journal of biomedical materials research.

[83]  I. Date,et al.  Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. , 1996, Journal of neurosurgery.

[84]  C. Colton,et al.  Bioengineering in development of the hybrid artificial pancreas. , 1991, Journal of biomechanical engineering.

[85]  Ales Prokop,et al.  Water Soluble Polymers for Immunoisolation II: Evaluation of Multicomponent Microencapsulation Systems , 1998 .

[86]  A. Anilkumar,et al.  New capsule with tailored properties for the encapsulation of living cells. , 1998, Journal of biomedical materials research.

[87]  A. Fournier,et al.  Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability. , 1992, Transplantation proceedings.

[88]  B. Říhová,et al.  Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers , 1996 .

[89]  G. Reach,et al.  A Method for Obtaining Monodispersed Cells from Isolated Porcine Islets of Langerhans , 1995, The International journal of artificial organs.

[90]  P. Morris A critical review of immunosuppressive regimens. , 1996, Transplantation proceedings.

[91]  D. Emerich,et al.  Polymer-Encapsulated Genetically Modified Cells Continue to Secrete Human Nerve Growth Factor for over One Year in Rat Ventricles: Behavioral and Anatomical Consequences , 1996, Experimental Neurology.

[92]  E. Klein,et al.  Sensitization of rat T cells to syngeneic tumor cultures by cocultivation in diffusion chambers. , 1977, Zeitschrift fur Immunitatsforschung. Immunobiology.

[93]  Anderson,et al.  Host response to tissue engineered devices. , 1998, Advanced drug delivery reviews.

[94]  G W Plant,et al.  Neural tissue engineering: from polymer to biohybrid organs. , 1996, Biomaterials.

[95]  W. Jochle Forty years of control of the oestrous cycle in ruminants: progress made, unresolved problems and the potential impact of sperm encapsulation technology. , 1993 .

[96]  P. Aebischer,et al.  Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells , 1994, Experimental Neurology.

[97]  H. Amemiya,et al.  Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation. , 1992, Transplantation proceedings.

[98]  Ales Prokop,et al.  Water Soluble Polymersfor Immunoisolation I: Complex Coacervation and Cytotoxicity , 1998 .

[99]  Y. Ikada,et al.  Entrapment of islets into reversible disulfide hydrogels. , 1998, Journal of biomedical materials research.

[100]  J. Osebold,et al.  Cellular Immunity of Mice Infected with Listeria monocytogenes in Diffusion Chambers , 1968, Journal of bacteriology.

[101]  A. Anilkumar,et al.  Control and measurement of permeability for design of microcapsule cell delivery system. , 1998, Journal of biomedical materials research.

[102]  C. Sgro Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. , 1995, Toxicology.

[103]  R. Gates,et al.  Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans. , 1972, Lancet.

[104]  P. de Vos,et al.  Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? , 1999, Diabetes.

[105]  Ivar Storrø,et al.  Alginate as immobilization material: III. Diffusional properties , 1992, Biotechnology and bioengineering.

[106]  M. Sefton,et al.  Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release. , 1993, Journal of biomedical materials research.

[107]  Hydrogel Applications for Encapsulated Cellular Transplants , 1994 .

[108]  P. Aebischer,et al.  The Dawn of Biotechnology in Artificial Organs , 1995, ASAIO journal.

[109]  M J Lysaght,et al.  Artificial pancreas using living beta cells:. effects on glucose homeostasis in diabetic rats. , 1977, Science.

[110]  A. Prokop,et al.  Purification of Polymers Used for Fabrication of an Immunoisolation Barrier a , 1997, Annals of the New York Academy of Sciences.

[111]  G. Korbutt,et al.  Cotransplantation of Allogeneic Islets With Allogeneic Testicular Cell Aggregates Allows Long-Term Graft Survival Without Systemic Immunosuppression , 1997, Diabetes.

[112]  M. Shoichet,et al.  In vivo biostability of a polymeric hollow fibre membrane for cell encapsulation. , 1996, Biomaterials.

[113]  Shelley R. Winn,et al.  Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line , 1991, Experimental Neurology.

[114]  M. Pinget,et al.  Pancreatic islet macroencapsulation: a new device for the evaluation of artificial membrane. , 1996, Artificial organs.

[115]  P. Aebischer,et al.  Review: Tissue engineering in the nervous system , 1994, Biotechnology and bioengineering.

[116]  F T Gentile,et al.  Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. , 1991, Science.

[117]  Y. Ikada,et al.  Encapsulation of mammalian cells into synthetic polymer membranes using least toxic solvents. , 1997, Journal of biomaterials science. Polymer edition.

[118]  B. Hering,et al.  Large-scale production of Ba(2+)-alginate-coated islets of Langerhans for immunoisolation. , 2009, Experimental and clinical endocrinology.

[119]  Li,et al.  Materials for immunoisolated cell transplantation. , 1998, Advanced drug delivery reviews.

[120]  B. Kulseng,et al.  TNF Production from Peripheral Blood Mononuclear Cells in Diabetic Patients after Stimulation with Alginate and Lipopolysaccharide , 1996, Scandinavian journal of immunology.

[121]  D K MacCallum,et al.  Culture and growth characteristics of chondrocytes encapsulated in alginate beads. , 1989, Connective tissue research.

[122]  T. Chang,et al.  Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[123]  Sensenbrenner Ll,et al.  Growth and differentiation of normal and leukemic human bone marrow cells cultured in diffusion chambers. , 1977 .

[124]  L. G. Cima,et al.  Engineering human tissue , 1993 .

[125]  N. Déglon,et al.  A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. , 1997, Human gene therapy.

[126]  P. De Vos,et al.  Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets , 1997, Diabetologia.

[127]  G. Skjåk‐Braek,et al.  An immunologic basis for the fibrotic reaction to implanted microcapsules. , 1991, Transplantation proceedings.

[128]  F. Widmer,et al.  A new multinozzle encapsulation/immobilisation system to produce uniform beads of alginate , 1998 .

[129]  I. Chu,et al.  Characterization of modified alginate-poly-L-lysine microcapsules. , 2008, Artificial organs.

[130]  N. Forest,et al.  Cartilage formation by fetal rat chondrocytes cultured in alginate beads: a proposed model for investigating tissue-biomaterial interactions. , 1998, Journal of biomedical materials research.

[131]  C. Peterson,et al.  Silica Sol-Gel Encapsulation of Pancreatic Islets , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[132]  D. Ducassou,et al.  Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. , 1987, Journal of microencapsulation.

[133]  M. Sefton,et al.  Metabolic Activity and Proliferation of Cho Cells in Hydroxyethyl Methacrylate-Methyl Methacrylate (Hema-Mma) Microcapsules , 1993, Cell transplantation.

[134]  T. Loudovaris,et al.  Destruction of xenografts but not allografts within cell impermeable membranes. , 1992, Transplantation proceedings.

[135]  R. Palmiter,et al.  Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[136]  P. Tresco Encapsulated cells for sustained neurotransmitter delivery to the central nervous system , 1994 .

[137]  P. Bruheim,et al.  Alginate polycation microcapsules. II. Some functional properties. , 1996, Biomaterials.

[138]  Clark K. Colton,et al.  Engineering challenges in cellencapsulation technology , 1996 .

[139]  C. Kiparissides,et al.  Mathematical modelling of protein diffusion in microcapsules: A comparison with experimental results , 1991 .

[140]  P. Vos,et al.  The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats , 1994 .

[141]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[142]  Y. Tsutsumi,et al.  A Quantitative in vivo Method of Analyzing Human Tumor‐induced Angiogenesis in Mice Using Agarose Microencapsulation and Hemoglobin Enzyme‐linked Immunosorbent Assay , 1995, Japanese journal of cancer research : Gann.

[143]  W. D. Peterson,et al.  Complex Coacervate Microcapsules for Mammalian Cell Culture and Artificial Organ Development , 1993, Biotechnology progress.

[144]  T. Chang Hybrid artificial cells: microencapsulation of living cells. , 1992, ASAIO journal.

[145]  C. Baquey,et al.  “Inverted Microcarriers” for Cell Cultures Made by Polymerization of Shells around Agarose Microspheres in a Non-Cytotoxic Procedure , 1991 .

[146]  F T Gentile,et al.  Poly(ethylene oxide)‐grafted thermoplastic membranes for use as cellular hybrid bio‐artificial organs in the central nervous system , 1994, Biotechnology and bioengineering.

[147]  F. Leblond,et al.  PROTECTION OF ISLETS OF LANGERHANS FROM ANTIBODIES BY MICROENCAPSULATION WITH ALGINATE‐POLY‐L‐LYSINE MEMBRANES1 , 1993, Transplantation.

[148]  T. Harris,et al.  Mathematical modelling of immobilized animal cell growth. , 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

[149]  P. Vos,et al.  Upscaling the production of microencapsulated pancreatic islets , 1997 .

[150]  Cole Lb,et al.  An attack of tetanus. , 1968 .

[151]  R. Langer,et al.  A Novel Synthetic Method for Hybridoma Cell Encapsulation , 1991, Bio/Technology.

[152]  H. Amemiya,et al.  Agarose microcapsule applied in islet xenografts (hamster to mouse). , 1992, Transplantation proceedings.

[153]  E. Doherty,et al.  Transport characterization of membranes for immunoisolation. , 1996, Biomaterials.

[154]  R. Simmons,et al.  TNF and IL-1 generation by human monocytes in response to biomaterials. , 1992, Journal of biomedical materials research.

[155]  A. Sun,et al.  Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[156]  J. Stillström Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[157]  D. Maysinger,et al.  Drug delivery to the nervous system. , 1997, Trends in biotechnology.

[158]  M. Pasch,et al.  Complement as a promiscuous signal transduction device. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[159]  D. Emerich,et al.  Providing pharmacological access to the brain : alternate approaches , 1994 .

[160]  M R Grever,et al.  In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.

[161]  S. Kubota,et al.  In vitro studies on a new method for islet microencapsulation using a thermoreversible gelation polymer, N-isopropylacrylamide-based copolymer. , 2008, Artificial organs.

[162]  A. Sun,et al.  Encapsulation of viable cells within polyacrylate membranes , 1986, Biotechnology and bioengineering.

[163]  A. Powers,et al.  Evaluation of microcapsule permeability via inverse size exclusion chromatography. , 1996, Analytical biochemistry.

[164]  O. Weislow,et al.  Feasibility of cellular microencapsulation technology for evaluation of anti-human immunodeficiency virus drugs in vivo. , 1990, Journal of the National Cancer Institute.

[165]  W. Stevenson,et al.  Microcapsules through polymer complexation. I: Complex coacervation of polymers containing a high charge density. , 1991, Biomaterials.

[166]  H. Ohtani,et al.  Procollagen‐positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body , 1998, The Journal of pathology.

[167]  A. Sun,et al.  Encapsulation of Rat Islets of Langerhans Prolongs Xenograft Survival in Diabetic Mice , 1986, Diabetes.

[168]  Y. Bae,et al.  Insulin release from islets of Langerhans entrapped in a poly(N-isopropylacrylamide-co-acrylic acid) polymer gel. , 1999, Journal of biomaterials science. Polymer edition.

[169]  M. Sefton,et al.  Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion , 1994, Biotechnology and bioengineering.

[170]  H. Katinger,et al.  Entrapment of animal cells for the production of biomolecules such as monoclonal antibodies. , 1983, Developments in biological standardization.

[171]  Patrick A Tresco,et al.  Polymer-Encapsulated PC12 Cells: Long-Term Survival and Associated Reduction in Lesion-Induced Rotational Behavior , 1992, Cell transplantation.

[172]  A. Sun,et al.  Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. , 2008, Artificial organs.

[173]  Patrick Aebischer,et al.  Transplantation of a Polymer-Encapsulated Cell Line Genetically Engineered to Release NGF , 1993, Experimental Neurology.

[174]  F. F. Wang,et al.  Preparation and application of poly(vinylamine)/alginate microcapsules to culturing of a mouse erythroleukemia cell line. , 1992, Biotechnology and bioengineering.

[175]  A. Cuschieri,et al.  Microencapsulation of human cells: its effects on growth of normal and tumour cells in vitro. , 1991, British Journal of Cancer.

[176]  D. Ducassou,et al.  In situ polymerization of a microencapsulating medium round living cells. , 1988, Journal of biomedical materials research.

[177]  K Hannig,et al.  Production of mitogen‐contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis , 1992, Electrophoresis.

[178]  R. Levin,et al.  Purification and characteristics of an alginase from Alginovibrio aquatilis , 1977, Applied and environmental microbiology.

[179]  G. Ackerman,et al.  Bursa of Fabricius in Chickens: Possible Humoral Factor , 1965, Science.

[180]  M. Sefton,et al.  Microencapsulated human hepatoma (HepG2) cells: capsule-to-capsule variations in protein secretion and permeability , 1995 .

[181]  R. C. Johnson,et al.  Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy , 1997, Annals of the New York Academy of Sciences.

[182]  P. Gullino,et al.  Cell Culture on Artificial Capillaries: An Approach to Tissue Growth in vitro , 1972, Science.

[183]  R. Nebel,et al.  Microencapsulation of bovine spermatozoa for use in artificial insemination: a review. , 1993, Reproduction, fertility, and development.

[184]  D. Osoba,et al.  Evidence for a Humoral Thymus Factor Responsible for the Maturation of Immunological Faculty , 1963, Nature.

[185]  G L Bartlett,et al.  An improved design for general purpose diffusion chambers. , 1969, Transplantation.

[186]  A. Rabinovitch An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. , 1998, Diabetes/metabolism reviews.

[187]  T. Tsuji,et al.  Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating culture system. , 1991, Artificial organs.

[188]  T. Young,et al.  Evaluation of asymmetric poly(vinyl alcohol) membranes for use in artificial islets. , 1996, Biomaterials.

[189]  G. H. Algire,et al.  Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. , 1954, Journal of the National Cancer Institute.

[190]  D. Despommier,et al.  Diffusion chambers for inducing immunity to Trichinella spiralis in mice. , 1968, Experimental parasitology.

[191]  P. Aebischer,et al.  A bioartificial parathyroid. , 1986, ASAIO transactions.

[192]  P. Chang,et al.  Expression of human factor IX by microencapsulated recombinant fibroblasts. , 1993, Human gene therapy.

[193]  M. Sefton,et al.  Conformal Coating of Small Particles and Cell Aggregates at a Liquid‐Liquid Interface , 1999, Annals of the New York Academy of Sciences.

[194]  F. Cerra,et al.  Enhanced Morphology and Function in Hepatocyte Spheroids: A Model of Tissue Self-Assembly , 1998 .

[195]  P. Chang,et al.  Delivery of recombinant gene products with microencapsulated cells in vivo. , 1993, Human gene therapy.

[196]  P. Chang,et al.  Growth of recombinant fibroblasts in alginate microcapsules , 1994, Biotechnology and bioengineering.

[197]  J. Vacanti,et al.  A new method of xenotransplantation using autologous cartilage as an immunoisolation barrier for the transplantation of xenogeneic islets of Langerhans. , 1997, Transplantation proceedings.

[198]  A. Sun,et al.  The Use, in Diabetic Rats and Monkeys, of Artificial Capillary Units Containing Cultured Islets of Langerhans (Artificial Endocrine Pancreas) , 1977, Diabetes.

[199]  P Aebischer,et al.  Brain tissue reaction to permselective polymer capsules. , 1989, Journal of biomedical materials research.

[200]  P. Gullino,et al.  Hormone production by cells grown in vitro on artificial capillaries. , 1974, Experimental cell research.

[201]  P. Aebischer,et al.  Chitosan as a matrix for mammalian cell encapsulation. , 1994, Biomaterials.

[202]  H Iwata,et al.  Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. , 1994, Journal of biomedical materials research.

[203]  E. Shelton Differentiation of mouse thymus cultured in diffusion chambers. , 1966, The American journal of anatomy.

[204]  H. Ecke,et al.  Formation of new bone in diffusion chambers. , 1970, Minnesota medicine.

[205]  J. Hubbell,et al.  Immunoisolation of Adult Porcine Islets for the Treatment of Diabetes Mellitus , 1997, Annals of the New York Academy of Sciences.

[206]  P. Tresco,et al.  Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. , 1991, Journal of biomechanical engineering.

[207]  J. Lakey,et al.  Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. , 1996, The Journal of clinical endocrinology and metabolism.

[208]  P. de Vos,et al.  Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. , 1996, Transplantation.

[209]  N. Kedersha,et al.  Clonogenic cytotoxicity testing by microdrop encapsulation , 1993, Nature.

[210]  The rat epididymal fat pad as an implantation site for the study of microcapsule biocompatibility: validation of the method. , 1995, Journal of biomedical materials research.

[211]  P. de Vos,et al.  Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. , 1997, Transplantation.

[212]  S. Leskowitz,et al.  Restoration of Antibody Producing Capacity in Bursectomized Chickens by Bursal Grafts in Millipore® Chambers.∗ , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[213]  A. Sun,et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.

[214]  M. Cooper,et al.  Nonspecific stimulation of antibody production in surgically bursectomized chickens by bursa-containing diffusion chambers. , 1968, Journal of immunology.

[215]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[216]  P Aebischer,et al.  Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.

[217]  Guohua Chen,et al.  Temperature sensitivity of a hydrogel network containing different LCST oligomers grafted to the hydrogel backbone , 1998 .

[218]  A. Sun,et al.  Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. , 1992, Transplantation.

[219]  Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. , 1996 .

[220]  I. Chu,et al.  Poly(ethylenimine)‐reinforced liquid‐core capsules for the cultivation of hybridoma cells , 1992, Biotechnology and bioengineering.

[221]  M. Sefton,et al.  Secretion of recombinant proteins from hydroxyethyl methacrylate‐methyl methacrylate capsules , 1996, Biotechnology and bioengineering.

[222]  D. A. Cieslinski,et al.  Tissue engineering of a bioartificial kidney , 1994, Biotechnology and bioengineering.

[223]  P. Aebischer,et al.  Encapsulated cells as therapy. , 1999, Scientific American.

[224]  Takuyu Taki,et al.  TRANSPLANTATION OF XENOGENEIC CELLS SECRETING β-ENDORPHIN FOR PAIN TREATMENT: ANALYSIS OF THE ABILITY OF COMPONENTS OF COMPLEMENT TO PENETRATE THROUGH POLYMER CAPSULES. , 1997, Cell transplantation.

[225]  T. Chang,et al.  Secretion of Erythropoietin from Microencapsulated Rat Kidney Cells: Preliminary Results , 1993, The International journal of artificial organs.

[226]  B. Nordlinger,et al.  Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. , 1995, Biomaterials.

[227]  M. Sefton,et al.  Microencapsulation of live animal cells using polyacrylates , 1993 .

[228]  L. Vanhaelst,et al.  CORONARY-ARTERY DISEASE IN MYXŒDEMA , 1967 .

[229]  D. Gray Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. , 1997, British medical bulletin.

[230]  P. Vos,et al.  Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules , 1997 .

[231]  J. Nobrega,et al.  HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis. , 1998, Biomaterials.

[232]  P. Soon-Shiong,et al.  Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation , 1994, The Lancet.

[233]  P. Aebischer,et al.  Immunoisolated Xenogeneic Chromaffin Cell Therapy for Chronic Pain: Initial Clinical Experience , 1996 .

[234]  J. Brash,et al.  Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. , 1998, Journal of biomedical materials research.